MARKET

IOVA

IOVA

Iovance
NASDAQ

Real-time Quotes | Nasdaq Last Sale

22.62
-0.28
-1.22%
Closed 16:41 11/13 EST
OPEN
22.74
PREV CLOSE
22.90
HIGH
22.88
LOW
22.23
VOLUME
815.12K
TURNOVER
--
52 WEEK HIGH
26.59
52 WEEK LOW
7.26
MARKET CAP
2.85B
P/E (TTM)
-16.6790
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of IOVA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 9 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

IOVA News

  • 3 Cancer Treatment Stocks to Buy Right Now
  • MotleyFool.com.4d ago
  • Iovance up 12% premarket on positive lifileucel data
  • seekingalpha.5d ago
  • Why Iovance Biotherapeutics Shares Are Soaring Today
  • MotleyFool.com.5d ago
  • Iovance Biotherapeutics (IOVA) Investor Presentation - Slideshow
  • Seeking Alpha - Article.5d ago

More

Industry

Biotechnology & Medical Research
+0.42%
Pharmaceuticals & Medical Research
+0.16%

Hot Stocks

Name
Price
%Change

About IOVA

Iovance Biotherapeutics, Inc., formerly Lion Biotechnologies, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells. The Company's lead program is an adoptive cell therapy utilizing tumor-infiltrating lymphocytes, which are T cells derived from patients' tumors, for the treatment of metastatic melanoma. As of December 31, 2016, it had an on-going Phase II clinical trial of its lead product candidate, LN-144, TIL for the treatment of metastatic melanoma. The Company is developing LN-145 to treat cervical and head and neck cancers. It is collaborating with the National Cancer Institute to evaluate unmodified TIL in other solid tumor indications, such as ocular melanoma, bladder, breast and lung cancer. It is collaborating with the NCI to evaluate TIL in combination with the checkpoint inhibitor, Keytruda.
More

Webull offers Iovance Biotherapeutics Inc (IOVA) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.